MedPath

Effect of Aripiprazole and Risperidone in Improving Obsessive-compulsive symptoms in Bipolar patients

Phase 3
Conditions
Condition 1: Obsessive-compulsive disorder. Condition 2: Bipolar disorder.
Obsessive-compulsive disorder
Bipolar disorder
Registration Number
IRCT20170716035117N1
Lead Sponsor
Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

age between 18 and 65 years
A definitive diagnosis of Bipolar disorder with Obsessive-compulsive disorder based on DSM-5 criteria
Bipolar patients in Maintenance phase
Patients with ability to answer and evaluate with Yale Brown scale (Higher education level)
Patients with Yale-Brown Obsessive-Compulsive Scale 16 or higher

Exclusion Criteria

Acute and severe physical illness during study
Presence of unsafe pregnancy prevention method in women of reproductive age
Pregnancy
Bearst feeding
Substance abuse and alcohol abuse in the six months before study
Accompanied with other psychiatric disorders

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity obsessive compulsion. Timepoint: The beginning of the study and every four weeks until the twelfth week. Method of measurement: Yale Brown Obsessive-Compulsion Scale.
Secondary Outcome Measures
NameTimeMethod
The onset of side effects of drugs. Timepoint: Weeks four, eighth, twelfth. Method of measurement: Clinical examination.
© Copyright 2025. All Rights Reserved by MedPath